These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1844532)

  • 21. [Application of immunofluorescence and sandwich ELISA with double-antibodies in detection of human rabies].
    Sun LJ; Xu GL; Wang HL; Wu J; Hu ZH; Zhou YW
    Fa Yi Xue Za Zhi; 2007 Dec; 23(6):411-3. PubMed ID: 18402108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
    Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
    Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and diagnosis of rabies in Greece.
    Seimenis A; Manganà O; Nomicoù V
    Parassitologia; 1988; 30(1):93-5. PubMed ID: 3077442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modification of the incubation period of the fixed Babeş strain in relation to the nature of the host cells. The effects on viral titer and on the immunogenic value of rabies vaccines].
    Serban O; Toacsen E
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):87-91. PubMed ID: 6336510
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluorescence diagnosis of rabies and its advantages for rabies vaccination].
    Winkler C; Patzwaldt HG
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):179-90. PubMed ID: 4171966
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on an inactivated vaccine against rabies virus in domestic animals.
    Monaco F; Franchi PM; Lelli R
    Dev Biol (Basel); 2006; 125():233-9. PubMed ID: 16878481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A plaque-purified rabies virus (strains V-319) derived from a vampire bat (Desmodus rotundus) in Mexico: vaccine potential.
    Bijlenga G; Hernandez-Baumgarten EM
    Cornell Vet; 1984 Apr; 74(2):155-65. PubMed ID: 6467947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of cellular and humoral immune responses after immunization with different rabies vaccines.
    Pille ER; Vagabov MA; Karakuyumchan MK; Matevosyan KS
    Acta Virol; 1985 Mar; 29(2):137-42. PubMed ID: 2860797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental chronic rabies in the cat.
    Murphy FA; Bell JF; Bauer SP; Gardner JJ; Moore GJ; Harrison AK; Coe JE
    Lab Invest; 1980 Sep; 43(3):231-41. PubMed ID: 6995713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wild rabies virus detection by plaque assay from naturally infected brains in different species.
    Cardoso T; Pilz D
    Vet Microbiol; 2004 Nov; 103(3-4):161-7. PubMed ID: 15504587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of human rabies in north India.
    Ratho R; Grover R; Mahajan RC
    Indian J Pathol Microbiol; 2001 Jan; 44(1):41-4. PubMed ID: 12561994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thermostability of rabies vaccine, type Fuenzalida & Palacios, for human use].
    Albas A; Fuches RM; Gallina NM; Mendonça RM; Fang FL; Valentini EJ
    Rev Inst Med Trop Sao Paulo; 1992; 34(1):27-31. PubMed ID: 1284895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis for exposure to rabies in humans.
    Waters JR
    Can Med Assoc J; 1977 Oct; 117(8):860-3. PubMed ID: 334352
    [No Abstract]   [Full Text] [Related]  

  • 38. Specificity of the agar gel microimmunodiffusion test in rabies diagnostics.
    Wojciechowski KJ
    Acta Microbiol Pol; 1976; 25(2):145-52. PubMed ID: 59529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro inactivation of the rabies virus by ascorbic acid.
    Madhusudana SN; Shamsundar R; Seetharaman S
    Int J Infect Dis; 2004 Jan; 8(1):21-5. PubMed ID: 14690777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitive procedure for detecting residual viable virus in inactivated rabies vaccine.
    Mitchell JR; Everest RE; Anderson GR
    Appl Microbiol; 1971 Oct; 22(4):600-3. PubMed ID: 4943273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.